OXB honoured at 2025 CDMO Leadership Awards in ‘Cell & Gene Therapy – Global’ category

By Dr. Matthew Watson

OXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' category

Continued here:
OXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' category

Rapport Therapeutics to Present Data at the 2025 American Academy of Neurology Annual Meeting - March 22nd, 2025
FDA Approves New Prostate Cancer Imaging Agent Gozellix® - March 22nd, 2025
23andMe Launches New Homocysteine (MTHFR-Related) Genetic Report and Accompanying Lab Test - March 22nd, 2025
Biofrontera Inc. Reports Record Fiscal Year 2024 Financial Results and Provides a Business Update - March 22nd, 2025
Pharmaceutical industry delivers value proposition to Finnish Government: billions to be invested by 2030 - March 22nd, 2025
BioCardia to Host 2024 Financial Results and Corporate Update Conference Call on March 31, 2025 - March 22nd, 2025
PharmAla Completes Shipment of LaNeo™ MDMA to the University of Washington - March 22nd, 2025
Bright Green Corporation Announces the next steps for the completion of its restructuring plan - March 22nd, 2025
Opus Genetics Announces Pricing of Public Offering and Concurrent Private Placement with Proceeds of Over $20 Million - March 22nd, 2025
Clearmind Medicine’s FDA-Approved Clinical Trial for CMND-100 Moves Forward as Drug Arrives in the U.S., Advancing Toward Key Milestones - March 22nd, 2025
Opus Genetics Announces Presentation on Phentolamine Ophthalmic Solution 0.75% in Dim Light Disturbances at World Cornea Congress IX - March 22nd, 2025
Impact Biomedical Inc. Announcement Stock Activity/Pricing - March 22nd, 2025
I-Mab Announces Receipt Of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement - March 22nd, 2025
Better Choice Company Shareholders Overwhelmingly Approve Acquisition of SRx Health Solutions and Related Proposals - March 22nd, 2025
Annovis Provides Corporate Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results - March 22nd, 2025
Restore Value Slate Led by Mina Sooch Files Preliminary Proxy Materials for the Election of Six Highly Qualified Directors at the 2025 Annual Meeting... - March 22nd, 2025
Atea Pharmaceuticals Issues Statement Regarding Director Nominations - March 22nd, 2025
Genmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc. - March 22nd, 2025
Arialief Reviews (Is It Safe And Legit To Use?) What Do Arialief Consumer Reports Say About Its Efficacy? - March 22nd, 2025
Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of... - March 11th, 2025
BioCardia Announces Japanese Patent for Helix™ Biotherapeutic Delivery System - March 11th, 2025
PharmAla Signs Duchefa Farma as Exclusive Distributor in Netherlands - March 11th, 2025
Genmab Announces Johnson & Johnson Decision Regarding HexaBody®-CD38 - March 11th, 2025
Transactions under Novonesis’ share buyback program - March 11th, 2025
Dogecoin Cash, Inc. ($CBDS) Expands into Meme Coin Market with Formation of MEME COINS Inc. - March 11th, 2025
Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, names Albert P. Garcia-Romeu, Ph.D. as Chair of its Newly Created Scientific Advisory... - March 11th, 2025
Tevogen Bio Announces Unique T Cell Vaccine Under Development and Files Patent with the USPTO - March 11th, 2025
MSInsight Announces €1.6 Million in Seed Fundraising to Revolutionize MSI Cancer Diagnosis - March 11th, 2025
Orion Corporation: Transfer of 191,911 own B shares on 10 March 2025 - March 11th, 2025
Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025 - March 11th, 2025
Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences - March 11th, 2025
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - March 11th, 2025
Coherus BioSciences Reports Fourth Quarter, Full Year 2024 Financial Results and Provides Business Update - March 11th, 2025
CervoMed Announces Positive Results from the Extension Phase of its Phase 2b Clinical Study of Neflamapimod in Patients with Dementia with Lewy Bodies - March 11th, 2025
Royalty Financing with HCRx: GENFIT Announces Approval of the Amendment of the Terms and Conditions of its 2025 OCEANEs - March 11th, 2025
Druid City Vital Care Recognized at Vital Care Infusion Services Annual Conference - March 11th, 2025
Abpro Statement on the Departure of Former CEO Ian Chan - March 11th, 2025
Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health... - March 11th, 2025
ProstaVive Reviews (Consumer Report Analysis) Is It Safe And Effective For Healthy Prostate Function? - March 11th, 2025
TREMFYA® (guselkumab) receives positive CHMP opinion for treatment of adult patients with moderately to severely active ulcerative colitis - March 1st, 2025
AIM announces Paul Goepfert, MD, as the principal investigator for the planned clinical study of Ampligen and FluMist as a vaccine for avian influenza - March 1st, 2025
Ultimovacs ASA: Approval and publication of prospectus - March 1st, 2025
Novartis data presentations at AAAAI and AAD underscore commitment to advancing treatment of hidradenitis suppurativa (HS) and chronic spontaneous... - March 1st, 2025
Arcutis to Present Two Posters at the 83rd American Academy of Dermatology Annual Meeting - March 1st, 2025
InflaRx to Showcase Vilobelimab’s Role in Immuno-Dermatology at the 2025 AAD Annual Meeting - March 1st, 2025
Alumis Announces Late-Breaker Psoriasis Presentation of 52-week Phase 2 OLE Data for ESK-001 at 2025 American Academy of Dermatology Annual Meeting... - March 1st, 2025
CORRECTION: Spectral AI Schedules 2024 Fourth Quarter and Full Year Financial Results and Conference Call - March 1st, 2025
Orion Corporation: Managers’ transactions – Niclas Lindstedt - March 1st, 2025
ORYZON Announces the Voting Results of February 2025 Extraordinary General Shareholders' Meeting - March 1st, 2025
SRx Health Solutions Granted Final Order to Proceed with the Acquisition by Better Choice Company - March 1st, 2025
Valneva Receives EMA’s Positive CHMP Opinion for Adolescent Label Extension for Chikungunya Vaccine IXCHIQ® - March 1st, 2025
Bavarian Nordic Receives Marketing Authorization in Europe for Chikungunya Vaccine for Persons Aged 12 and Older - March 1st, 2025
Orion Corporation: Managers’ transactions – Outi Vaarala - March 1st, 2025
Apogee Therapeutics to Host Conference Call to Report Interim Results from the Phase 1 Healthy Volunteer Trial for APG990 and Provide Combination... - March 1st, 2025
Tevogen Bio Founder and CEO Dr. Ryan Saadi Named to 2025 NJBIZ Power 100, Celebrating Innovation and Leadership in Accessible T Cell Therapy - March 1st, 2025
Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives - March 1st, 2025
4DMT Reports Full Year 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones - March 1st, 2025
Longeveron® Announces Full-Year 2024 Financial Results and Provides Business Update - March 1st, 2025
Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences - March 1st, 2025
Genmab to Participate in a Fireside Chat at the 45th Annual TD Cowen Health Care Conference - February 20th, 2025
NAYA Biosciences Announces Nomination of New Board Members - February 20th, 2025
Intrommune Therapeutics Announces Publication of OMEGA Study in Peanut Allergic Adults in Annals of Allergy, Asthma & Immunology - February 20th, 2025
OrphAI Therapeutics Announces Appointment of Dr. Aaron Waxman to Board of Directors - February 20th, 2025
Radiance Biopharma Enters Exclusive License For ROR-1 Targeted Antibody Drug Conjugate - February 20th, 2025
Vivoryon Therapeutics N.V. Shares Highlights from Virtual R&D Update with KOL Speakers - February 20th, 2025
NurExone Biologic Recognized as a 2025 TSX Venture 50™ Top Performing Stock - February 20th, 2025
Better Choice Company Adjourns Special Meeting of Stockholders to March 21, 2025 - February 20th, 2025
COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing - February 20th, 2025
Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2024 After Market Close on February 26, 2025 - February 20th, 2025
GRI Bio Announces Reverse Stock Split - February 20th, 2025
PacBio to Participate in TD Cowen's 45th Annual Health Care Conference - February 20th, 2025
ANI Pharmaceuticals to Present at Raymond James’ Institutional Investors and Leerink Partners Global Healthcare Conferences in March - February 20th, 2025
Intelligent Bio Solutions Inc. Announces Proposed Public Offering of Common Stock - February 20th, 2025
Relay Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights on February 26, 2025 - February 20th, 2025
Zealand Pharma Announces Financial Results for the Full Year 2024 - February 20th, 2025
argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025 - February 20th, 2025
EG 427 raises €27 million in successful Series B co-led by Andera Partners and Bpifrance to finance on-going clinical study and platform... - February 20th, 2025
Apellis and Sobi Announce EMA Validation of Indication Extension Application for Aspaveli® (pegcetacoplan) for C3G and Primary IC-MPGN - February 20th, 2025
Citryll Demonstrates a Broader Therapeutic Potential for CIT-013 in the Treatment of Inflammatory Disorders - February 20th, 2025
Grace Therapeutics Announces Private Placement Financing of up to $30 Million - February 11th, 2025

Global News Feed commento

Comments Off | data

March 22nd, 2025

About... Dr. Matthew Watson

This author published 6112 posts in this site.

Comments are closed.

Previous post - Next post

OXB honoured at 2025 CDMO Leadership Awards in ‘Cell & Gene Therapy – Global’ category

By Dr. Matthew Watson

About... Dr. Matthew Watson

Share

Comments are closed.

Categories

Archives

Recommended Sites